Skip to main content

Table 2 Definitions of outcomes in opioid substitution investigations

From: The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol

Outcome

Definition

Measurement of variable (units)

Statistical estimates and measurement of association of this outcome

Studies

Continued illicit drug abuse

Abstaining from illicit opioid use throughout treatment.

-Urine toxicology screening

OR, rate ratio

[39, 46, 47, 50, 51]

-Self-reported drug use

 

Retention in treatment

Proportion or participants completing treatment and days in treatment from beginning of the study until the last day of therapy.

-Number of days patient remains in treatment (days)

Comparing means (SD), HR, adjusted HR using Cox model, rate ratio, Kaplan-Meier estimator

[39, 47, 52–54]

Adverse events

Reaction to drugs and/or change in health status during course of therapy.

-Interviews

t-test

[30, 39, 51, 54]

-Physical examination

-Randomly recorded at visits

-Total number of adverse events per day